Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

537 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection.
Kosaka M, Ushiki A, Ikuyama Y, Hirai K, Matsuo A, Hachiya T, Hanaoka M. Kosaka M, et al. Among authors: hanaoka m. Antimicrob Agents Chemother. 2017 Nov 22;61(12):e01173-17. doi: 10.1128/AAC.01173-17. Print 2017 Dec. Antimicrob Agents Chemother. 2017. PMID: 28893787 Free PMC article.
The usefulness of a combination of age, body mass index, and blood urea nitrogen as prognostic factors in predicting oxygen requirements in patients with coronavirus disease 2019.
Goto N, Wada Y, Ikuyama Y, Akahane J, Kosaka M, Ushiki A, Kitaguchi Y, Yasuo M, Yamamoto H, Matsuo A, Hachiya T, Ideura G, Yamazaki Y, Hanaoka M. Goto N, et al. Among authors: hanaoka m. J Infect Chemother. 2021 Dec;27(12):1706-1712. doi: 10.1016/j.jiac.2021.08.009. Epub 2021 Aug 13. J Infect Chemother. 2021. PMID: 34412984 Free PMC article.
A case of organizing pneumonia induced by tocilizumab.
Ikegawa K, Hanaoka M, Ushiki A, Yamamoto H, Kubo K. Ikegawa K, et al. Among authors: hanaoka m. Intern Med. 2011;50(19):2191-3. doi: 10.2169/internalmedicine.50.5497. Epub 2011 Oct 1. Intern Med. 2011. PMID: 21963739 Free article.
Clinical analysis of patients treated with afatinib for advanced non-small cell lung cancer: A Nagano Lung Cancer Research Group observational study.
Wada Y, Koyama S, Kuraishi H, Miyahara T, Yoshiike F, Agatsuma T, Yamamoto R, Ono Y, Suzuki T, Hachiya T, Gomi D, Tateishi K, Hanaoka M, Koizumi T. Wada Y, et al. Among authors: hanaoka m. Respir Investig. 2016 Nov;54(6):462-467. doi: 10.1016/j.resinv.2016.07.003. Epub 2016 Aug 25. Respir Investig. 2016. PMID: 27886858
Predictive value of post-treatment C-reactive protein-to-albumin ratio in locally advanced non-small cell lung cancer patients receiving durvalumab after chemoradiotherapy.
Araki T, Tateishi K, Komatsu M, Sonehara K, Wasamoto S, Koyama S, Yoshiike F, Hama M, Nishie K, Kondo D, Agatsuma T, Kato A, Takata M, Kanda S, Hanaoka M, Koizumi T. Araki T, et al. Among authors: hanaoka m. Thorac Cancer. 2022 Jul;13(14):2031-2040. doi: 10.1111/1759-7714.14484. Epub 2022 May 26. Thorac Cancer. 2022. PMID: 35616056 Free PMC article.
Clinical analysis of EGFR-positive non-small cell lung cancer patients treated with first-line afatinib: A Nagano Lung Cancer Research Group.
Sonehara K, Kobayashi T, Tateishi K, Morozumi N, Yoshiike F, Hachiya T, Ono Y, Takasuna K, Agatsuma T, Masubuchi T, Matsuo A, Tanaka H, Morikawa A, Hanaoka M, Koizumi T. Sonehara K, et al. Among authors: hanaoka m. Thorac Cancer. 2019 May;10(5):1078-1085. doi: 10.1111/1759-7714.13047. Epub 2019 Apr 20. Thorac Cancer. 2019. PMID: 31006178 Free PMC article.
537 results